0001225208-13-019840.txt : 20130911
0001225208-13-019840.hdr.sgml : 20130911
20130911155532
ACCESSION NUMBER: 0001225208-13-019840
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130909
FILED AS OF DATE: 20130911
DATE AS OF CHANGE: 20130911
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeFord John A
CENTRAL INDEX KEY: 0001403373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 131091083
MAIL ADDRESS:
STREET 1: C R BARD INC
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2013-09-09
0000009892
BARD C R INC /NJ/
BCR
0001403373
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Sr. VP Sci Tech and Clin Afrs
Common Stock
2013-09-09
4
M
0
18000.0000
88.7550
A
53489.6436
D
Common Stock
2013-09-09
4
M
0
10364.0000
86.1450
A
63853.6436
D
Common Stock
2013-09-09
4
S
0
767.0000
118.0961
D
63086.6436
D
Common Stock
2013-09-09
4
S
0
27597.0000
117.8884
D
35489.6436
D
Common Stock
12.6460
I
401(k) Plan
Option (Right to Buy)
88.7550
2013-09-09
4
M
0
18000.0000
0.0000
D
2018-07-09
Common Stock
18000.0000
0.0000
D
Option (Right to Buy)
86.1450
2013-09-09
4
M
0
10364.0000
0.0000
D
2020-12-08
Common Stock
10364.0000
10364.0000
D
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Includes 10.0379 shares acquired under the Company's Dividend Reinvestment Plan from July 27, 2013 to September 9, 2013. Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from July 27, 2013 to September 9, 2013.
Represents the weighted average sales price for price increments ranging from $118.07 to $118.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $117.07 to $118.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 0.538 shares acquired under the Company's 401(k) Plan from July 27, 2013 to September 9, 2013.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan.
Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options vested in accordance with schedule upon achievement of certain performance criteria.
Myra McGinley, Attorney-in-Fact
2013-09-11